Hanseatic Management Services’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-6,472
| Closed | -$959K | – | 180 |
|
|
2020
Q2 | $959K | Sell |
6,472
-2,253
| -26% | -$334K | 0.81% | 41 |
|
|
2020
Q1 | $950K | Buy |
8,725
+2,346
| +37% | +$255K | 1.01% | 23 |
|
|
2019
Q4 | $735K | Buy |
+6,379
| New | +$735K | 0.67% | 68 |
|
|
2018
Q4 | – | Sell |
-246
| Closed | -$22K | – | 254 |
|
|
2018
Q3 | $22K | Sell |
246
-4,903
| -95% | -$438K | 0.02% | 215 |
|
|
2018
Q2 | $507K | Sell |
5,149
-5
| -0.1% | -$492 | 0.44% | 88 |
|
|
2018
Q1 | $614K | Sell |
5,154
-14
| -0.3% | -$1.67K | 0.59% | 69 |
|
|
2017
Q4 | $657K | Buy |
5,168
+123
| +2% | +$15.6K | 0.66% | 59 |
|
|
2017
Q3 | $593K | Sell |
5,045
-2,575
| -34% | -$303K | 0.67% | 55 |
|
|
2017
Q2 | $608K | Buy |
+7,620
| New | +$608K | 0.31% | 119 |
|
|
2015
Q3 | – | Sell |
-11,944
| Closed | -$1.43M | – | 356 |
|
|
2015
Q2 | $1.43M | Buy |
11,944
+6,008
| +101% | +$720K | 0.63% | 53 |
|
|
2015
Q1 | $620K | Sell |
5,936
-22,164
| -79% | -$2.31M | 0.33% | 89 |
|
|
2014
Q4 | $2.73M | Buy |
+28,100
| New | +$2.73M | 1.4% | 10 |
|